Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19
© 2023 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of the Australian and New Zealand Society for Immunology, Inc..
Indigenous peoples globally are at increased risk of COVID-19-associated morbidity and mortality. However, data that describe immune responses to SARS-CoV-2 infection in Indigenous populations are lacking. We evaluated immune responses in Australian First Nations peoples hospitalized with COVID-19. Our work comprehensively mapped out inflammatory, humoral and adaptive immune responses following SARS-CoV-2 infection. Patients were recruited early following the lifting of strict public health measures in the Northern Territory, Australia, between November 2021 and May 2022. Australian First Nations peoples recovering from COVID-19 showed increased levels of MCP-1 and IL-8 cytokines, IgG-antibodies against Delta-RBD and memory SARS-CoV-2-specific T cell responses prior to hospital discharge in comparison with hospital admission, with resolution of hyperactivated HLA-DR+ CD38+ T cells. SARS-CoV-2 infection elicited coordinated ASC, Tfh and CD8+ T cell responses in concert with CD4+ T cell responses. Delta and Omicron RBD-IgG, as well as Ancestral N-IgG antibodies, strongly correlated with Ancestral RBD-IgG antibodies and Spike-specific memory B cells. We provide evidence of broad and robust immune responses following SARS-CoV-2 infection in Indigenous peoples, resembling those of non-Indigenous COVID-19 hospitalized patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Immunology and cell biology - 101(2023), 10 vom: 24. Nov., Seite 964-974 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Wuji [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 02.11.2023 Date Revised 18.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/imcb.12691 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362223505 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362223505 | ||
| 003 | DE-627 | ||
| 005 | 20240218231856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/imcb.12691 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1298.xml |
| 035 | |a (DE-627)NLM362223505 | ||
| 035 | |a (NLM)37725525 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Wuji |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.11.2023 | ||
| 500 | |a Date Revised 18.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of the Australian and New Zealand Society for Immunology, Inc. | ||
| 520 | |a Indigenous peoples globally are at increased risk of COVID-19-associated morbidity and mortality. However, data that describe immune responses to SARS-CoV-2 infection in Indigenous populations are lacking. We evaluated immune responses in Australian First Nations peoples hospitalized with COVID-19. Our work comprehensively mapped out inflammatory, humoral and adaptive immune responses following SARS-CoV-2 infection. Patients were recruited early following the lifting of strict public health measures in the Northern Territory, Australia, between November 2021 and May 2022. Australian First Nations peoples recovering from COVID-19 showed increased levels of MCP-1 and IL-8 cytokines, IgG-antibodies against Delta-RBD and memory SARS-CoV-2-specific T cell responses prior to hospital discharge in comparison with hospital admission, with resolution of hyperactivated HLA-DR+ CD38+ T cells. SARS-CoV-2 infection elicited coordinated ASC, Tfh and CD8+ T cell responses in concert with CD4+ T cell responses. Delta and Omicron RBD-IgG, as well as Ancestral N-IgG antibodies, strongly correlated with Ancestral RBD-IgG antibodies and Spike-specific memory B cells. We provide evidence of broad and robust immune responses following SARS-CoV-2 infection in Indigenous peoples, resembling those of non-Indigenous COVID-19 hospitalized patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Australian First Nations peoples | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a RBD and N antibodies | |
| 650 | 4 | |a SARS-CoV-2-specific T cells | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Clemens, E Bridie |e verfasserin |4 aut | |
| 700 | 1 | |a Kedzierski, Lukasz |e verfasserin |4 aut | |
| 700 | 1 | |a Chua, Brendon Y |e verfasserin |4 aut | |
| 700 | 1 | |a Mayo, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Lonzi, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Hinchcliff, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Rigas, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Middleton, Bianca F |e verfasserin |4 aut | |
| 700 | 1 | |a Binks, Paula |e verfasserin |4 aut | |
| 700 | 1 | |a Rowntree, Louise C |e verfasserin |4 aut | |
| 700 | 1 | |a Allen, Lilith F |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Hyon-Xhi |e verfasserin |4 aut | |
| 700 | 1 | |a Petersen, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Chaurasia, Priyanka |e verfasserin |4 aut | |
| 700 | 1 | |a Krammer, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Wheatley, Adam K |e verfasserin |4 aut | |
| 700 | 1 | |a Kent, Stephen J |e verfasserin |4 aut | |
| 700 | 1 | |a Rossjohn, Jamie |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Adrian |e verfasserin |4 aut | |
| 700 | 1 | |a Lynar, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Nelson, Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Thi Ho |e verfasserin |4 aut | |
| 700 | 1 | |a Davies, Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Kedzierska, Katherine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunology and cell biology |d 1992 |g 101(2023), 10 vom: 24. Nov., Seite 964-974 |w (DE-627)NLM012699896 |x 1440-1711 |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2023 |g number:10 |g day:24 |g month:11 |g pages:964-974 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/imcb.12691 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2023 |e 10 |b 24 |c 11 |h 964-974 | ||